îāļāđāļāļŦāļē
îž
î
āļĨāđāļāļāļāļīāļ
îāļāđāļāļŦāļē
î
Zenas Biopharma Inc
ZBIOîāđāļāļīāđāļĄāļĨāļāđāļāļĢāļēāļĒāļāļēāļĢāļāļīāļāļāļēāļĄ
29.630USD
-3.420-10.35%
āļāļīāļÂ 09-23 16:00ïžETïž
1.87BāļĄāļđāļĨāļāđāļēāļāļĨāļēāļ
āļāļēāļāļāļļāļP/E TTM
āđāļāļĩāđāļĒāļ§āļāļąāļ Zenas Biopharma Inc āļāļĢāļīāļĐāļąāļ
Zenas BioPharma, Inc. is a clinical-stage global biopharmaceutical company focused on the development and commercialization of transformative therapies for patients with autoimmune diseases. The Company's lead product candidate, obexelimab, is a bifunctional monoclonal antibody designed to bind both CD19 and FcyRIIb, which are broadly present across B cell lineage, to inhibit the activity of cells that are implicated in many autoimmune diseases without depleting them. The Company is developing obexelimab as a potential immunology and inflammation (I&I) franchise for patients in several autoimmune diseases. The first three indications it is pursuing include immunoglobulin G4-related disease (IgG4-RD), relapsing multiple sclerosis (RMS) and systemic lupus erythematosus (SLE). Its other programs include ZB002 (an anti-TNFÎą monoclonal antibody), ZB004 (a CTLA-4-Ig fusion), and ZB001 and related programs. ZB002 is a recombinant human monoclonal antibody directed at human TNFÎą.
Zenas Biopharma Inc āđāļāļĢāđāļāļĨāđ
îāļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZBIO
āļāļ·āđāļāļāļĢāļīāļĐāļąāļZenas Biopharma Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 13, 2024
āļāļĩāļāļĩāđāļMoulder (Leon O)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ130
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļSep 13
āļāļĩāđāļāļĒāļđāđ1000 Winter St, Suite 1200
āđāļĄāļ·āļāļWALTHAM
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ02451
āđāļāļĢāļĻāļąāļāļāđ18572712954
āđāļ§āđāļāđāļāļāđhttps://zenasbio.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļZBIO
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 13, 2024
āļāļĩāļāļĩāđāļMoulder (Leon O)
āļāļđāđāļāļĢāļīāļŦāļēāļĢāļāļĢāļīāļĐāļąāļāļāļāļ Zenas Biopharma Inc
îāļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Leon O. Moulder, Jr.
Mr. Leon O. Moulder, Jr.
Founder, Chairman of the Board of Director, Chief Executive Officer
Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Chief Business Officer, Chief Financial Officer
Chief Business Officer, Chief Financial Officer
--
--
Ms. Patricia Allen
Ms. Patricia Allen
Independent Director
Independent Director
--
--
Mr. James P. (Jim) Boylan
Mr. James P. (Jim) Boylan
Lead Independent Director
Lead Independent Director
--
--
Mr. Patrick G. Enright
Mr. Patrick G. Enright
Independent Director
Independent Director
--
--
Ms. Hongbo Lu, Ph.D.
Ms. Hongbo Lu, Ph.D.
Independent Director
Independent Director
--
--
Mr. Jake R. Nunn
Mr. Jake R. Nunn
Independent Director
Independent Director
--
--
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
āļāļ·āđāļ
āļāļ·āđāļ/āļāļģāđāļŦāļāđāļ
āļāļģāđāļŦāļāđāļ
āļāļēāļĢāļāļ·āļāļŦāļļāđāļ
āđāļāļĨāļĩāđāļĒāļ
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Joseph L. (Joe) Farmer, J.D.
Mr. Joseph L. (Joe) Farmer, J.D.
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
President, Chief Operating Officer, Principal Financial Officer and Principal Accounting Officer
2.31K
+57.93%
Mr. Leon O. Moulder, Jr.
Mr. Leon O. Moulder, Jr.
Founder, Chairman of the Board of Director, Chief Executive Officer
Founder, Chairman of the Board of Director, Chief Executive Officer
--
--
Ms. Jennifer Fox
Ms. Jennifer Fox
Chief Business Officer, Chief Financial Officer
Chief Business Officer, Chief Financial Officer
--
--
Ms. Patricia Allen
Ms. Patricia Allen
Independent Director
Independent Director
--
--
āļāļģāļāļēāļĄāļāļĩāđāļāļāļāđāļāļĒ
āđāļāļĢāļāļ·āļāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Zenas Biopharma Inc?
îāļāļđāđāļāļ·āļāļŦāļļāđāļāļŦāđāļēāļāļąāļāļāļąāļāđāļĢāļāļāļāļ Zenas Biopharma Inc āđāļāđāđāļāđ: Mr. Joseph L. (Joe) Farmer, J.D.